Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atrial Fibrillation.

Jayant Bagai1, Boaz Avitall

  • 1Department of Cardiology, University of Illinois at Chicago, M/C 787, Chicago, IL 60612, USA.

Current Treatment Options in Cardiovascular Medicine
|July 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study.

Circulation. Cardiovascular interventions·2025
Same author

The never-ending search for safe and effective RF cardiac tissue ablation.

Journal of cardiovascular electrophysiology·2024
Same author

Have the cake and eat it too: PFA, a case of a technological miracle?

Journal of cardiovascular electrophysiology·2023
Same author

Visualization of electrographic flow fields of increasing complexity and detection of simulated sources during spontaneously persistent AF in an animal model.

Frontiers in cardiovascular medicine·2023
Same author

Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review.

Respiratory medicine case reports·2022
Same author

Electrographic flow mapping for atrial fibrillation: theoretical basis and preliminary observations.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2022
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Converting atrial fibrillation (AF) to normal sinus rhythm is recommended for symptomatic patients, especially those with underlying heart disease. For asymptomatic individuals or those with persistent AF, rate control is often preferred.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) management strategies vary based on patient characteristics and disease severity.
  • Conversion to normal sinus rhythm aims to improve outcomes, but risks must be weighed against benefits.

Purpose of the Study:

  • To outline indications and contraindications for converting atrial fibrillation to normal sinus rhythm.
  • To discuss the role of rate control and anticoagulation in AF management.
  • To guide decisions on post-conversion therapy to prevent recurrence.

Main Methods:

  • Review of current guidelines and clinical evidence for AF management.
  • Analysis of patient factors influencing the choice between rhythm control and rate control.
  • Consideration of stroke risk, ventricular function, and symptom burden.

Related Experiment Videos

Main Results:

  • Conversion is indicated for symptomatic patients, particularly younger individuals with healthy hearts, and those with diseased hearts or over 65 where sinus rhythm improves outcomes.
  • Rate control is the first-line strategy for asymptomatic patients, those with long-standing persistent AF, or AF during acute illness.
  • Anticoagulation is crucial for patients not in sinus rhythm, especially those with increased stroke risk.

Conclusions:

  • Rhythm control via cardioversion is recommended for specific AF patient groups, considering symptom severity and underlying cardiac health.
  • Rate control and anticoagulation are vital components of AF management, particularly for asymptomatic or high-risk patients.
  • Post-conversion therapy decisions should be individualized based on recurrence risk and comorbidities.